Sun Pharma Advanced Research Company Limited (SPARC) Share Analysis
NSE · Healthcare · Pharmaceuticals
Sun Pharma Advanced Research Company Limited (NSE: SPARC) is an Indian listed company in the Pharmaceuticals sector and a constituent of NIFTY Microcap 250. As of 14 Nov 2026, the share price was ₹206.00, P/E 4.05, ROE 279%.
Get the AI verdict on SPARC: BUY, BUY ON DIPS, WAIT or EXIT
Sign in for the full analysis — AI fundamental and technical analysis, recent news, and one verdict with an entry zone, two targets and a stop-loss, for a 3-month, 1-year, 3-year or 5-year horizon. A free plan is available.
SPARC chart with trendlines
Is SPARC a buy right now?
Sign in free for the AI verdict with entry zone, targets and stop-loss.
About Sun Pharma Advanced Research Company Limited
Stored fundamentals as of 14 Nov 2026 — not a live quote. Signed-in analysis uses same-day data.
SPARC key facts
| Price and valuation | |
|---|---|
| Share price | ₹206.00 |
| Market cap | ₹6,680 Cr |
| P/E ratio | 4.05 |
| P/B ratio | 4.64 |
| EPS | ₹50.40 |
| Book value per share | ₹44.40 |
| Dividend yield | 0% |
| 52-week range | |
| 52-week high | ₹289.00 |
| 52-week low | ₹108.00 |
| Face value | ₹1.00 |
| Shareholding pattern | |
| Promoters | 65.68% |
| FIIs | 3.74% |
| DIIs | 0.11% |
| Public | 30.48% |
Index membership: NIFTY Microcap 250.
Learn to read these numbers
- Metrics glossary — what P/E, ROE, ROCE and debt-to-equity mean.
- Investment Blogs — free lessons on fundamental and technical analysis.
- AI stock picks and Discover stocks by sector and index.
- How Stock-Analyze works — what the AI analysis and verdict cover.